更短的时间、更低的成本，是传统药企争相拥抱AI的核心驱动力。进入2026年，AI制药领域的合作签约明显提速。2月10日，AI制药企业英硅智能（03696.HK）宣布与康哲药业（00867.HK）达成数千万港元AI药物研发合作。公告显示，双方将在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据协议条款，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，...
Source Link更短的时间、更低的成本，是传统药企争相拥抱AI的核心驱动力。进入2026年，AI制药领域的合作签约明显提速。2月10日，AI制药企业英硅智能（03696.HK）宣布与康哲药业（00867.HK）达成数千万港元AI药物研发合作。公告显示，双方将在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据协议条款，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.